about
Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation.Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.TRAIL combinations: The new 'trail' for cancer therapy (Review).Bardoxolone-methyl inhibits migration and metabolism in MCF7 cells.Helicobacter pylori Induces Serine Phosphorylation of EGFR via Novel TAK1-p38 Activation Pathway in an HB-EGF-Independent Manner.Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells.Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.Apoptotic cell death by the novel natural compound, cinobufotalin.Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells.Hyperthermia and radiation reduce the toxic side-effects of bufadienolides for cancer therapy.Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy.Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways.The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer.Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model.Prospects for repurposing CNS drugs for cancer treatmentRole of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cellsImmune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
P50
Q33464331-534CDA29-9634-49E4-A71F-530CEA56DC6FQ37211816-38BB5D61-89D4-4A38-8820-E5C8BD6B8873Q37719944-0A8BFB5A-0636-4F98-BAA2-0E972F37FF64Q38712952-AB0799C9-6A12-4B2C-BBA0-F3A45C92BEC9Q38907139-A5BBCC4F-79D4-4191-ABB3-1B22AF288A66Q38907483-89215F58-74A1-49FC-8DF5-BEDF268B9113Q39557718-C4AEF562-C808-461D-822A-AAEB0A85D421Q39568374-FF8CAF21-45EE-433A-B485-9ED09FF42129Q39779098-0F05228D-E415-4CF5-A2CA-77CCA326CB12Q40979526-948381C2-DE91-459D-8816-F229314884BDQ42094991-30F522E5-A0DF-458A-88E8-DD9DD45F3353Q50053731-A4498991-E970-437D-8FAE-25E89704FEAFQ52684450-0B1B0E48-CE53-419A-A69B-734967942814Q52721823-D132A28B-5ABF-4E8B-BC99-5A0B0D193330Q64106166-C0612159-15F7-4F16-A019-6C923F4A8223Q90262361-59903368-2773-4BF7-AC81-25F36A76C737Q93159547-BDA09105-063B-4A44-B6B0-F1C86B2B2BA5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alaa Refaat
@ast
Alaa Refaat
@en
Alaa Refaat
@es
Alaa Refaat
@nl
Alaa Refaat
@sl
type
label
Alaa Refaat
@ast
Alaa Refaat
@en
Alaa Refaat
@es
Alaa Refaat
@nl
Alaa Refaat
@sl
prefLabel
Alaa Refaat
@ast
Alaa Refaat
@en
Alaa Refaat
@es
Alaa Refaat
@nl
Alaa Refaat
@sl
P106
P1153
35337752300
P31
P496
0000-0002-7821-2500